Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dr Reddy’s introduces generic Protonix tablets in US
According to the company, Pantoprazole Sodium delayed-released tablets are the generic version of Protonix tablets. Protonix is in a group of drugs called proton pump inhibitors which decreases
According to the company, Pantoprazole Sodium delayed-released tablets are the generic version of Protonix tablets. Protonix is in a group of drugs called proton pump inhibitors which decreases
The proposed transaction is subject to customary closing conditions, including notification and clearance under certain antitrust statutes. Perrigo expects the transaction to close during its fourth fiscal quarter
Matrix said that the FDA’s tentative approval under PEPFAR means that its product meets all of the agency’s manufacturing quality, safety and efficacy standards. Lamivudine and Zidovudine tablets,
Symbiance delivers data solutions for pharmaceutical and biotechnology companies. Symbiance includes a clinical data management unit, biostatistical analysis, and SAS programming divisions supporting Phase I through IV clinical
Soligenix has completed a Phase 1A clinical trial of RiVax which showed that the immunogen was safe and induced antibodies anticipated to protect humans from ricin exposure. Further,
Under the agreement, Unity/MCC is expected to have all distribution and marketing rights in the US, and will increase their market share in new presses for Novartis and
In the collaboration, RBM will discover and also confirm plasma protein biomarker candidates identified from the multicenter Biomarkers for SMA (BforSMA) clinical study sponsored by the SMA Foundation
In the study, the company will investigate the safety and efficacy and pharmacokinetics of Resminostat in conjunction with Folfiri versus Folfiri alone in the control arm. In the
Under the contract, Evotec is expected to use its Screening Platform and proprietary GPCR modeling software for identifying and validating novel modulators against various targets selected by Takeda
Under the pact, both the companies have decided to establish a joint venture, Amrutanjan Pharmaessense Ltd (Pharmaessense). Amrutanjan’s fine chemical division Pharmaessense provides value added servics to several